Tissium’s €50 Million Series C Financing Round

Goodwin Procter advised Cathay Health on the deal.TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, has closed a Series C round of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here